Uroepithelial carcinoma in association with cyclophosphamide ingestion

E. F. Fuchs, R. Kay, R. Poole, J. M. Barry, H. D. Pearse

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

The association of daily oral cyclophosphamide with the development of transitional cell carcinoma or squamous cell carcinoma of the bladder has been documented. We report the first 2 cases of transitional cell carcinoma of the renal pelvis and an additional 4 cases of transitional cell carcinoma of the bladder following cyclophosphamide ingestion. Patients who have been taking daily oral cyclophosphamide for a prolonged period should have excretory urography, cystoscopy and bladder mucosal biopsies performed as part of a cancer surveillance protocol.

Original languageEnglish (US)
Pages (from-to)544-545
Number of pages2
JournalUnknown Journal
Volume126
Issue number4
DOIs
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Uroepithelial carcinoma in association with cyclophosphamide ingestion'. Together they form a unique fingerprint.

  • Cite this